Free Trial
NASDAQ:EKSO

Ekso Bionics (EKSO) Stock Price, News & Analysis

Ekso Bionics logo
$0.72 0.00 (0.00%)
(As of 11/21/2024 ET)

About Ekso Bionics Stock (NASDAQ:EKSO)

Key Stats

Today's Range
$0.70
$0.73
50-Day Range
$0.71
$1.25
52-Week Range
$0.70
$3.13
Volume
75,607 shs
Average Volume
114,704 shs
Market Capitalization
$15.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Buy

Company Overview

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Ekso Bionics Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
53rd Percentile Overall Score

EKSO MarketRank™: 

Ekso Bionics scored higher than 53% of companies evaluated by MarketBeat, and ranked 550th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ekso Bionics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Ekso Bionics has only been the subject of 2 research reports in the past 90 days.

  • Read more about Ekso Bionics' stock forecast and price target.
  • Earnings Growth

    Earnings for Ekso Bionics are expected to grow in the coming year, from ($0.48) to ($0.15) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ekso Bionics is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ekso Bionics is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Ekso Bionics has a P/B Ratio of 1.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Ekso Bionics' valuation and earnings.
  • Percentage of Shares Shorted

    0.34% of the outstanding shares of Ekso Bionics have been sold short.
  • Short Interest Ratio / Days to Cover

    Ekso Bionics has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ekso Bionics has recently decreased by 47.81%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Ekso Bionics does not currently pay a dividend.

  • Dividend Growth

    Ekso Bionics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.34% of the outstanding shares of Ekso Bionics have been sold short.
  • Short Interest Ratio / Days to Cover

    Ekso Bionics has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ekso Bionics has recently decreased by 47.81%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Ekso Bionics has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.48 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Ekso Bionics this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Ekso Bionics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.10% of the stock of Ekso Bionics is held by insiders.

  • Percentage Held by Institutions

    Only 6.42% of the stock of Ekso Bionics is held by institutions.

  • Read more about Ekso Bionics' insider trading history.
Receive EKSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter.

EKSO Stock News Headlines

Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com
Ekso Bionics to showcase device technology in ‘AI for Good’ Webinar
What Comes Next Could Be a Once-in-a-Lifetime Opportunity
A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.
Ekso Gains, While Gearing up for “AI for Good”
See More Headlines

EKSO Stock Analysis - Frequently Asked Questions

Ekso Bionics' stock was trading at $2.50 at the beginning of 2024. Since then, EKSO stock has decreased by 71.2% and is now trading at $0.72.
View the best growth stocks for 2024 here
.

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) announced its quarterly earnings data on Monday, October, 28th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.02. The business had revenue of $4.13 million for the quarter, compared to the consensus estimate of $6 million. Ekso Bionics had a negative trailing twelve-month return on equity of 83.09% and a negative net margin of 62.95%.

Ekso Bionics's stock reverse split before market open on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 4th 2016. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

Shares of EKSO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ekso Bionics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), TransEnterix (TRXDW), Meta Platforms (META), Tesla (TSLA), Editas Medicine (EDIT) and Micron Technology (MU).

Company Calendar

Last Earnings
10/28/2024
Today
11/21/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/03/2025

Industry, Sector and Symbol

Sector
Medical
Industry
General industrial machinery,
Sub-Industry
Machinery
Current Symbol
NASDAQ:EKSO
Previous Symbol
OTCMKTS:EKSOD
Employees
60
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.50
High Stock Price Target
$9.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+663.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-15,200,000.00
Pretax Margin
-62.95%

Debt

Sales & Book Value

Annual Sales
$18.28 million
Book Value
$0.68 per share

Miscellaneous

Free Float
20,656,000
Market Cap
$15.84 million
Optionable
Optionable
Beta
1.47

Social Links

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:EKSO) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners